Skeletal muscle insulin resistance (IR) is a primary cause for prediabetes, an intermediary condition of higher-than-normal blood glucose levels that left untreated progresses into type 2 diabetes (T2D). A number of contributing factors associated with skeletal muscle IR include aberrant mitochondrial function, elevated reactive oxygen species, inflammation, and reduction in oxidative slow-twitch type 1 skeletal muscle fibers. One leading candidate for reversing skeletal muscle IR is Syntaxin 4 (STX4), traditionally a cell surface transmembrane SNARE protein for GLUT4 vesicle exocytosis that our lab has recently discovered is also localized in the skeletal muscle outer mitochondrial membrane. Importantly, we previously demonstrated that doxycycline-induced skeletal muscle specific STX4 overexpression in obese, prediabetes male transgenic mice (skmSTX4-iOE) reversed IR and mitochondrial dysfunction associated with diabetes muscle. However, the precise mechanisms of how STX4 restores skeletal muscle insulin sensitivity remains to be determined. To test glucose uptake and insulin sensitivity we used the “gold standard” method of hyper-insulinemic-euglycemic clamp in chow-fed skmSTX4-iOE STX4 enriched mice against non-induced controls, we identified improved glucose clearance was only associated with increased insulin sensitivity in type 1 fiber rich soleus muscle. On the other hand, insulin tolerance test studies in doxycycline-induced skeletal muscle STX4 knockout (skmSTX4-iKO) male mice revealed the opposite phenotype, suggesting that STX4 activity in slow-twitch skeletal muscle may be a contributing factor for the reversal of IR. To determine the heterogeneity of STX4 activity between different skeletal muscle fibers, myogenic precursors and intercalating non-muscular tissue in skeletal muscle STX4 enriched skmSTX4-iOE mice, we aim to use our established single nuclear RNA-Sequencing platform (snRNA-Seq) to identify pathways in distinct fiber types associated with STX4 enrichment. Overall, our work aims to determine the functional requirements of STX4 in slow-and-fast twitch skeletal muscle fiber types and identify novel molecular pathways that may serve as useful targets for the reversal/protection against skeletal muscle IR in prediabetes and T2D. This study was supported by grants from the National Institutes of Health (DK067912, DK1129712 and DK102233) and City of Hope Shared Resources Pilot Grant. This is the full abstract presented at the American Physiology Summit 2024 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.
Read full abstract